Katalysen Ventures

Investment Director and co-founder of Apollonian with extensive experience at the European Commission's Directorate-General for Research and Innovation, where he led the establishment of RESAVER, Europe's first multi-country pension fund.

A lifelong entrepreneur who founded, grew, and exited multiple companies, playing an early role in fintech from the 1980s onward and later in music and corporate finance. His experience as a venture builder gave rise to Katalysen.

A strategy, M&A, and organizational development advisor with seven years of experience, formerly leading the Financial Services Industry group at Monitor Deloitte in Stockholm and doing analytical work at a San Francisco commercial bank.

A venture partner with a decade of experience in startups, finance, and cross-border strategy, having studied and worked across Asia and Europe. At Katalysen since 2019 (previously COO), he helped design the Venture Targeter framework and focuses on global reach and cross-border expansion.

A quantitative finance leader and academic, co-founder of Sila and Investimizer, partner at Numeraire Financial, and professor at Hebrew University with a background at Bank of America Merrill Lynch, Citadel, and other institutions.

Chair of investment and advisory group Tyson & Blake, with deep global financial markets experience and involvement in multiple public listings, including taking Metacon AB public as its CEO.

A healthcare executive who has held senior roles at MSD, Pfizer, and Abbott, managing large P&Ls and teams and building international healthcare businesses at scale.

A capital markets professional with experience across investment banking, asset management, VC/PE, and consulting, including a senior role at Nordea Asset Management in Luxembourg. He joined Katalysen in early 2026 to lead investor relations and corporate finance.

A serial inventor and entrepreneur, former Chief Architect at Microsoft and co-founder of Intellectual Ventures, holding more than 1,200 patents across multiple fields.

Founder of regulated alternative investment fund manager Resscapital AB, with an international finance background including roles at Schroders, Bear Stearns, and Merrill Lynch specializing in OTC derivatives.